# US 2024/0251841 A1 · Composition comprising a constituent, derivative or extract of cannabis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0251841 A1
- Document ID: US20240251841A1
- Status: Published application
- Kind: A1
- Application number: 18/580,066
- Filed: 2022-07-21
- Published: 2024-08-01
- Earliest claimed: 2021-07-22
- Assignees: Nicoventures Trading Limited
- Applicants: Nicoventures Trading Limited
- Inventors: Steven ALDERMAN; Thomas POOLE; Michael DANIEL; Kai TANG; Keyi XU; Karina MCQUILLAN
- Web page: https://patentgrep.com/patent/US20240251841A1

## CPC

- A24B 15/16: of tobacco substitutes
- A24B 13/00: Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff (reconstituted tobacco products A24B3/14)
- A61K 9/0007: {Effervescent (A61K9/0065 takes precedence)}
- A61K 9/006: {Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays}
- A61K 31/658: {o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol}
- A24B: MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention relates to compositions comprising a constituent, derivative or extract of cannabis in solution or in a solubilised form. The invention also relates to products including such compositions and methods of manufacturing them.

## Claims

### Claim 1

A composition comprising one or more constituent, derivative or extract of cannabis in solution or in a solubilised form and a carrier material.

### Claim 2 (depends on 1)

A composition as claimed in claim 1, the composition comprising the one or more constituent, derivative or extract of cannabis and a lipophilic solvent in which the constituent, derivative or extract of cannabis is soluble.

### Claim 3 (depends on 2)

A composition as claimed in claim 2, wherein the lipophilic solvent is an oil such as palm oil, palm kernel oil, soybean oil, sunflower oil, cottonseed oil, coconut oil, and combinations thereof, wherein the oil may be hydrogenated, partially hydrogenated, or nonhydrogenated.

### Claim 4 (depends on 1, 2, 3)

A composition as claimed in any one of claims 1 to 3, wherein the constituent, derivative or extract of cannabis is one or more compounds selected from:
cannabinoids; terpenes; alkaloids; and flavonoids.

### Claim 5 (depends on 1, 2, 3, 4)

A composition as claimed in any one of claims 1 to 4, wherein the constituent, derivative or extract of cannabis is selected from the group consisting of: cannabigerol (CBG), cannabichromene (CBC), cannabidiol (CBD), tetrahydrocannabinol (THC), cannabinol (CBN), cannabinodiol (CBDL), cannabicyclol (CBL), cannabivarin (CBV), tetrahydrocannabivarin (THCV), cannabidivarin (CBDV), cannabichromevarin (CBCV), cannabigerovarin (CBGV), cannabigerol monomethyl ether (CBGM), cannabinerolic acid, cannabidiolic acid (CBDA), cannabinol propyl variant (CBNV), cannabitriol (CBO), tetrahydrocannabmolic acid (THCA), and tetrahydrocannabivarinic acid (THCV A).

### Claim 6 (depends on 1, 2, 3, 4, 5)

A composition as claimed in any one of claims 1 to 5, wherein the constituent, derivative or extract of cannabis is present in an amount of from about 0.1 to about 30% by weight, based on the total weight of the composition.

### Claim 7 (depends on 1, 2, 3, 4, 5, 6)

A composition as claimed in any one of claims 1 to 6, wherein the carrier material comprises a water soluble material.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6, 7)

A composition as claimed in any one of claims 1 to 7, wherein the carrier comprises a water soluble material selected from the group consisting of: sugar alcohols; disaccharides; cellulose and its derivatives; starch and its derivatives; dextrins; dextrates; natural gums; and cellulosics.

### Claim 9 (depends on 8)

A composition as claimed in claim 8, wherein the water soluble material is selected from the group consisting of: mannitol, sorbitol, xylitol, isomalt, erythritol, arabitol, ribitol, maltitol, dulcitol, iditol and lactitol guar gum, acacia gum (also known as gum arabic), xanthan gum, locust bean gum, gellan gum, alginates and sodium alginates, hydroxypropyl methylcellulose (H PMC), hydroxypropyl methylcellulose acetate succinate (HPMCAS), polyvinylpyrrolidone (PVP), polyethylene glycol (PEG), polyethylene oxide (PEO), Macrogol 15 Hydroxystearate (Solutol HS 15®), and Vitamin E Polyethylene Glycol Succinate (Vit E TPGS).

### Claim 10 (depends on 1)

A composition as claimed in any one of claim 1, to 9, further comprising a disintegrant selected from the group consisting of: croscarmellose, sodium starch glycolate, and crospovidone, povidone (PVP); and the like.

### Claim 11 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

A composition as claimed in any one of claim 1 to 10, further comprising an effervescent agent or combination of agents.

### Claim 12 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11)

A composition as claimed in any one of claims 1 to 11, further comprising a surfactant.

### Claim 13 (depends on 12)

A composition as claimed in claim 12, wherein the surfactant is selected from the group consisting of: glyceryl monooleate; and sodium lauryl sulfate (sodium dodecyl sulfate, SLS, or SDS), docusate sodium, lecithin, polyoxyethylene sorbitan fatty acid esters (Polysorbate, Tween®), polyoxyethylene 15 hydroxy stearate (Macrogol 15 hydroxy stearate, Solutol HS15®), polyoxyethylene castor oil derivatives (Cremophor® EL, ELP, RH 40), polyoxyethylene stearates (Myrj®), sorbitan fatty acid esters (Span®), polyoxyethylene alkyl ethers (Brij®), polyoxyethylene nonylphenol ether (Nonoxynol®), sugar esters and lecithins.

### Claim 14 (depends on 12, 13)

A composition as claimed in claim 12 or claim 13, wherein the composition comprises surfactant in an amount of from about 0.5 to about 20% by weight, based on the total weight of the composition.

### Claim 15 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

A composition as claimed in any one of claims 1 to 14, wherein release of the one or more constituent, derivative or extract of cannabis from the composition begins within a period of 5, 10, 15 or 30 seconds following exposure of the composition to water.

### Claim 16 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)

A composition as claimed any one of claims 1 to 15, wherein release of the one or more constituent, derivative or extract of cannabis from the composition is over a period of at least 5, 10, 15, 20, 25, 30, 45 or 60 minutes following exposure to water.

### Claim 17 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)

A composition as claimed in any one of claims 1 to 16, comprising an additive which slows or inhibits crystallisation of the one or more constituent, derivative or extract of cannabis in an aqueous environment, optionally wherein the additive is selected from the group consisting of polyvinylpyrrolidone (PVP), hydroxypropyl cellulose (HPC), hydroxypropyl methylcellulose (HPMC) and carboxymethyl cellulose (CMC).

### Claim 18 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

A composition as claimed in any one of claims 1 to 17, comprising a further active agent.

### Claim 19 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18)

A composition as claimed in any one of claims 1 to 18, comprising a further flavour or sensate.

### Claim 20 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19)

A composition as claimed in any one of claims 1 to 19, in the form of a solid unit dosage form, a powder or granules.

### Claim 21 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20)

A composition as claimed in any one of claims 1 to 20, having a volume mean particle size of from about 50 μm to about 500 μm.

### Claim 22 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21)

An oral product for providing buccal delivery of one or more constituent, derivative or extract of cannabis, comprising a composition as claimed in any one of claims 1 to 21.

### Claim 23 (depends on 22)

An oral product as claimed in claim 22, wherein the release of one or more constituent, derivative or extract of cannabis from the oral product begins within a period of 5, 10, 15 or 30 seconds following exposure to the aqueous environment of the oral cavity.

### Claim 24 (depends on 22, 23)

An oral product as claimed in claim 22 or claim 23, wherein the one or more constituent, derivative or extract of cannabis is released from the oral product over a period of at least 5, 10, 15, 20, 25, 30, 45 or 60 minutes following exposure to the aqueous environment of the oral cavity.

### Claim 25 (depends on 22, 23, 24)

An oral product as claimed in any one of claims 22 to 24, comprising a pouch containing the composition.

### Claim 26 (depends on 22, 23, 24, 25)

An oral product as claimed in any one of claims 22 to 25, comprising a dissolving strip comprising the composition.

### Claim 27 (depends on 26)

An oral product as claimed in claim 26, the dissolving strip comprising a bioadhesive.

### Claim 28 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21)

A method for preparing a composition as claimed in any one of claims 1 to 21, wherein a solution comprising one or more constituent, derivative or extract of cannabis is combined with a carrier material to form the composition with the carrier material carrying or surrounding the constituent, derivative or extract of cannabis.
